<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36373223</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2796</ISSN><JournalIssue CitedMedium="Internet"><Volume>293</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of internal medicine</Title><ISOAbbreviation>J Intern Med</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 condition in the German working population: A cross-sectional study of 200,000 registered stem cell donors.</ArticleTitle><Pagination><StartPage>354</StartPage><EndPage>370</EndPage><MedlinePgn>354-370</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/joim.13587</ELocationID><Abstract><AbstractText Label="BACKGROUND">The SARS-CoV-2 pandemic has strained health systems worldwide, and infection numbers continue to rise. While previous data have already shown that many patients suffer from symptoms for months after an acute infection, data on risk factors and long-term outcomes are incomplete, particularly for the working population.</AbstractText><AbstractText Label="OBJECTIVES">We aimed to provide information on the prevalence of post-COVID-19 conditions in a subset of the German working-age population (18-61 years old) and to analyze risk factors.</AbstractText><AbstractText Label="METHODS">We conducted an online survey with a health questionnaire among registered potential stem cell donors with or without a self-reported history of polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection. Logistic regression models were used to examine the risks of severity of acute infection, sex, age, body mass index, diabetes mellitus, and arterial hypertension medication on post-COVID-19 symptoms.</AbstractText><AbstractText Label="RESULTS">A total of 199,377 donors reported evaluable survey questionnaires-12,609 cases had a history of SARS-CoV-2 infection and 186,768 controls had none. Overall, cases reported physical, cognitive, and psychological complaints more frequently compared to controls. Increased rates of complaints persisted throughout 15 months postinfection, for example, 28.4%/19.3% of cases/controls reported fatigue (p&#xa0;&lt;0.0001) and 9.5%/3.6% of cases/controls reported loss of concentration (p&#xa0;&lt;0.0001). No significant differences were observed in the frequency of reported symptoms between 3 and 15 months postinfection. Multivariate analysis revealed a strong influence of the severity of the acute SARS-CoV-2 infection episode and age on the risk for post-COVID-19 conditions.</AbstractText><AbstractText Label="CONCLUSION">We report the prevalence of post-COVID-19 conditions in mainly unvaccinated individuals with SARS-CoV-2 infections between February 2020 and August 2021. The severity of the acute course and age were major risk factors. Vaccinations may reduce the risk of post-COVID-19 conditions by reducing the risk of severe infections.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Journal of Internal Medicine published by John Wiley &amp; Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bernas</LastName><ForeName>Stefanie N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0002-9700-6710</Identifier><AffiliationInfo><Affiliation>DKMS, Stem Cell Donor Registry, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldauf</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>DKMS, Clinical Trials Unit, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Real</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>DKMS, Clinical Trials Unit, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauter</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>DKMS, Stem Cell Donor Registry, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markert</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>DKMS, Stem Cell Donor Registry, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trost</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>DKMS, Clinical Trials Unit, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tausche</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonology, Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrends</LastName><ForeName>Uta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>School of Medicine, Department of Pediatrics, MRI Chronic Fatigue Center for Young People, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Alexander H</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0003-0979-5914</Identifier><AffiliationInfo><Affiliation>DKMS, Stem Cell Donor Registry, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DKMS, Clinical Trials Unit, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schetelig</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>DKMS, Clinical Trials Unit, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Stem Cell Transplantation, Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Intern Med</MedlineTA><NlmUniqueID>8904841</NlmUniqueID><ISSNLinking>0954-6820</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">survey</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>14</Day><Hour>2</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36373223</ArticleId><ArticleId IdType="pmc">PMC10107314</ArticleId><ArticleId IdType="doi">10.1111/joim.13587</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>El Bcheraoui C, Weishaar H, Pozo&#x2010;Martin F, Hanefeld J. Assessing COVID&#x2010;19 through the lens of health systems' preparedness: time for a change. Global Health. 2020;16:112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675393</ArticleId><ArticleId IdType="pubmed">33213482</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S, Williams MA. Confronting our next national health disaster&#x2014;long&#x2010;haul covid. N Engl J Med. 2021;385:577&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . In the wake of the pandemic&#x2014;preparing for long COVID. 2021. Policy Brief 39.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et&#xa0;al. Post&#x2010;COVID syndrome in non&#x2010;hospitalised patients with COVID&#x2010;19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et&#xa0;al. Sequelae in adults at 6 months after COVID&#x2010;19 infection. JAMA Netw Open. 2021;4:e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et&#xa0;al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27:601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . A clinical case definition of post COVID&#x2010;19 condition by a Delphi consensus. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, et&#xa0;al. Long&#x2010;term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta&#x2010;analysis. J Rehabil Med. 2020;52:jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et&#xa0;al. Immunological dysfunction persists for 8 months following initial mild&#x2010;to&#x2010;moderate SARS&#x2010;CoV&#x2010;2 infection. Nat Immunol. 2022;23:210&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et&#xa0;al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224:1839&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertow D, Stein S, Ramelli S, Grazioli A, Chung J&#x2010;Y, Singh M, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 infection and persistence throughout the human body and brain. 2021. Research Square PREPRINT (Version 1).</Citation></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et&#xa0;al. Evolution of antibody immunity to SARS&#x2010;CoV&#x2010;2. Nature. 2021;591:639&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et&#xa0;al. Gastrointestinal symptoms and fecal shedding of SARS&#x2010;CoV&#x2010;2 RNA suggest prolonged gastrointestinal infection. Med (N Y). 2022;3:371&#x2013;87.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, Rossler A, et&#xa0;al. Post&#x2010;acute COVID&#x2010;19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;28:S0016&#x2010;5085(22)00450&#x2010;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et&#xa0;al. Multiple early factors anticipate post&#x2010;acute COVID&#x2010;19 sequelae. Cell. 2022;185:881&#x2013;95.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Mukerji SS, Alabsi HS, Systrom D, Marciano SP, Felsenstein D, et&#xa0;al. Multisystem involvement in post&#x2010;acute sequelae of coronavirus disease 19. Ann Neurol. 2022;91:367&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmarinas MC, Jubilo KG, Samranvedhya J, et&#xa0;al. Risk of clinical sequelae after the acute phase of SARS&#x2010;CoV&#x2010;2 infection: retrospective cohort study. BMJ. 2021;373:n1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Aly Z, Xie Y, Bowe B. High&#x2010;dimensional characterization of post&#x2010;acute sequelae of COVID&#x2010;19. Nature. 2021;594:259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co&#x2010;occurrence, and evolution of long&#x2010;COVID features: a 6&#x2010;month retrospective cohort study of 273,618 survivors of COVID&#x2010;19. PLoS Med. 2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Mehrabadi MA, Abrihim H, Dutt N, et&#xa0;al. COVID symptoms, symptom clusters, and predictors for becoming a long&#x2010;hauler: looking for clarity in the haze of the pandemic. medRxiv. 2021. 10.1101/2021.03.03.21252086</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.03.21252086</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Ebinger JE, Mostafa R, Budde P, Gajewski J, Walker B, et&#xa0;al. Paradoxical sex&#x2010;specific patterns of autoantibody response to SARS&#x2010;CoV&#x2010;2 infection. J Transl Med. 2021;19:524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8716184</ArticleId><ArticleId IdType="pubmed">34965855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell ML, Catalfamo CJ, Farland LV, Ernst KC, Jacobs ET, Klimentidis YC, et&#xa0;al. Post&#x2010;acute sequelae of COVID&#x2010;19 in a non&#x2010;hospitalized cohort: results from the Arizona CoVHORT. PLoS One. 2021;16:e0254347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Muniz&#x2010;Pardos B, Shurlock J, Debruyne A, Steinacker JM, Borjesson M, Wolfarth B, et&#xa0;al. Collateral health issues derived from the covid&#x2010;19 pandemic. Sports Med Open. 2020;6:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414261</ArticleId><ArticleId IdType="pubmed">32770421</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly M, Sutin AR, Robinson E. Longitudinal changes in mental health and the COVID&#x2010;19 pandemic: evidence from the UK Household Longitudinal Study. Psychol Med. 2022;52:2549&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737138</ArticleId><ArticleId IdType="pubmed">33183370</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt AH, Sauter J, Baier DM, Daiss J, Keller A, Klussmeier A, et&#xa0;al. Immunogenetics in stem cell donor registry work: the DKMS example (Part 1). Int J Immunogenet. 2020;47:13&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7003907</ArticleId><ArticleId IdType="pubmed">31903698</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetelig J, Baldauf H, Wendler S, Heidenreich F, Real R, Kolditz M, et&#xa0;al. Risk factors for a severe course of COVID&#x2010;19 in persons aged 18 to 61. Dtsch Arztebl Int. 2021;118:288&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287760</ArticleId><ArticleId IdType="pubmed">34180791</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetelig J, Baldauf H, Wendler S, Heidenreich F, Real R, Kolditz M, et&#xa0;al. Severity of respiratory infections due to SARS&#x2010;CoV&#x2010;2 in working population: age and body mass index outweigh ABO blood group. medRxiv. 2021. 10.1101/2020.11.05.20226100</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.05.20226100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et&#xa0;al. Post&#x2010;covid syndrome in individuals admitted to hospital with covid&#x2010;19: retrospective cohort study. BMJ. 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ayoubkhani D, Pawelek P; Office for National Statistics
. Prevalence of ongoing symptoms following coronavirus (COVID&#x2010;19) infection in the UK. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7april2022 (2022). Accessed 30 May 2022.</Citation></Reference><Reference><Citation>Schetelig J, Heidenreich F, Baldauf H, Trost S, Falk B, Hossbach C, et&#xa0;al. Individual HLA&#x2010;A, &#x2010;B, &#x2010;C, and &#x2010;DRB1 genotypes are no major factors which determine COVID&#x2010;19 severity. Front Immunol. 2021;12:698193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8350391</ArticleId><ArticleId IdType="pubmed">34381451</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018;2:223&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30169257</ArticleId></ArticleIdList></Reference><Reference><Citation>
United Nations General Assembly
. International youth year: participation, development, peace. https://undocs.org/en/A/36/215 (1981). Accessed 30 April 2022.</Citation></Reference><Reference><Citation>
RKI COVID&#x2010;19
. CSV mit den aktuellen Covid&#x2010;19 Infektionen pro Tag (Zeitreihe). https://www.arcgis.com/home/item.html?id=f10774f1c63e40168479a1feb6c7ca74 (2022). Accessed 2 March 2022.</Citation></Reference><Reference><Citation>
German Federal Statistical Office (Destatis)
. https://www&#x2010;genesis.destatis.de/genesis/online (2022). Table 12411&#x2010;0006. Accessed 2 March 2022.</Citation></Reference><Reference><Citation>Rodriguez&#x2010;Rey R, Garrido&#x2010;Hernansaiz H, Collado S. Psychological impact and associated factors during the initial stage of the coronavirus (COVID&#x2010;19) pandemic among the general population in Spain. Front Psychol. 2020;11:1540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325630</ArticleId><ArticleId IdType="pubmed">32655463</ArticleId></ArticleIdList></Reference><Reference><Citation>Saladino V, Algeri D, Auriemma V. The psychological and social impact of covid&#x2010;19: new perspectives of well&#x2010;being. Front Psychol. 2020;11:577684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561673</ArticleId><ArticleId IdType="pubmed">33132986</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, Steig BA, Gaini S, et&#xa0;al. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73:e4058&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et&#xa0;al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sar&#x2010;van der Brugge S, Talman S, Boonman&#x2010;de Winter L, de Mol M, Hoefman E, van Etten RW, et&#xa0;al. Pulmonary function and health&#x2010;related quality of life after COVID&#x2010;19 pneumonia. Respir Med. 2021;176:106272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7701891</ArticleId><ArticleId IdType="pubmed">33302142</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wild P, Beutel M, Lackner KJ, M&#xfc;nzel T, Pfeiffer N, Strauch K. Gutenberg COVID&#x2010;19 Studie. https://www.unimedizin&#x2010;mainz.de/GCS/dashboard/#/app/pages/AktuelleErgebnisse/ergebnisselc (2022). Accessed 30 Dec 2021.</Citation></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID&#x2010;19 disease symptoms over time in the ComPaRe long COVID prospective e&#x2010;cohort. Nat Commun. 2022;13:1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et&#xa0;al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID&#x2010;19 in the New York City area. JAMA. 2020;323:2052&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et&#xa0;al. Estimates of the severity of coronavirus disease 2019: a model&#x2010;based analysis. Lancet Infect Dis. 2020;20:669&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, Bunthen E, et&#xa0;al. Long COVID occurrence in COVID&#x2010;19 survivors. Sci Rep. 2022;12:6039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8996498</ArticleId><ArticleId IdType="pubmed">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau&#x2010;Hyam M, Riley S, Darzi A, Cooke G, et&#xa0;al. Persistent COVID&#x2010;19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13:1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mule G, et&#xa0;al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28:611.e9&#x2013;e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et&#xa0;al. Male sex identified by global COVID&#x2010;19 meta&#x2010;analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11:6317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et&#xa0;al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et&#xa0;al. Persistent fatigue following SARS&#x2010;CoV&#x2010;2 infection is common and independent of severity of initial infection. PLoS One. 2020;15:e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt AH, Mengling T, Hernandez&#x2010;Frederick CJ, Rall G, Pingel J, Schetelig J, et&#xa0;al. Retrospective analysis of 37,287 observation years after peripheral blood stem cell donation. Biol Blood Marrow Transplant. 2017;23:1011&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28254417</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal A. Milder disease with Omicron: is it the virus or the pre&#x2010;existing immunity? Nat Rev Immunol. 2022;22:69&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767774</ArticleId><ArticleId IdType="pubmed">35046570</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ayoubkhani D, Bosworth M, King S; Office for National Statistics
. Self&#x2010;reported long COVID after two doses of a coronavirus (COVID&#x2010;19) vaccine in the UK. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidaftertwodosesofacoronaviruscovid19vaccineintheuk/26january2022 (2022). Accessed 30 May 2022.</Citation></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Jabal KA, et&#xa0;al. Association between vaccination status and reported incidence of post&#x2010;acute COVID&#x2010;19 symptoms in Israel: a cross&#x2010;sectional study of patients tested between March 2020 and November 2021. medRxiv. 2022. 10.1101/2022.01.05.22268800</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.05.22268800</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS&#x2010;CoV&#x2010;2 infection. Nat Med. 2022;28:1461&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et&#xa0;al. Trajectory of long covid symptoms after covid&#x2010;19 vaccination: community based cohort study. BMJ. 2022;377:e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>